AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Glimepiride+Metformin Hydrochloride in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Amaryl-M 2mg/500mg tablets Tablet Uncoated | 175/023 | Sanofi-Aventis South Africa (pty) ltd | active | 28 May 2029 |
Glimepiride+Metformin Hydrochloride — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Glimepiride+Metformin Hydrochloride, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Glimepiride+Metformin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.